Inhalation

INH0423

Issue link: https://www.e-digitaleditions.com/i/1496325

Contents of this Issue

Navigation

Page 21 of 44

20 April 2023 Inhalation Testing nasal product bioequivalence Offering automated actuation and shot weighing capabilities as recommended in the pharmacopoe- ias, the Vertus ® Plus is the ideal tool for testing nasal products, particularly for bioequivalence studies. With interchangeable interface plates, conveniently switch between delivered dose uniformity with the DUSA or Nasal Spray Dose Collector (NSDC), and particle sizing with the NGI or ACI. If you're looking to establish nasal product bioequivalence, get in touch today to find out how the Vertus ® Plus can help improve data integrity and boost testing efficiency: https://bit.ly/Vertus-Plus. Copley Scientific UK: +44 1159 616229 sales@copleyscientific.co.uk www.copleyscientific.com Semi- or fully automated testing systems Not only can you accurately control test variables such as air flow, firing force, speed and distance for dose wasting and collection, but each part of your semi- or fully automated testing system provides the traceable data needed for quality and compliance. Your 21 CFR Part 11 compliant data capture, storage and retrieval is available through our user friendly Relovex ® soft- ware. And your testing system can be installed as a standalone unit or integrated into Astech's full range of automated testing systems. Astech Projects UK: +44 1928 571797 www.astechprojects.co.uk An aerosol optical tweezers e Biral AOT-100 (Aerosol Optical Tweezers) enables non-specialists, such as laboratory scientists, students and technical staff, to explore the phys- ical and chemical behavior of individual micron- sized droplets with extraordinary precision. Initially, the instrument was predominantly used as a reli- able research tool to further the understanding of atmospheric and environmental aerosol. However, advances enable the AOT-100 to be applied to phar- maceutical research. is research looks to resolve the microphysical changes affecting pharmaceutical drop- lets as they enter the humid environment of the lung, with the aim of improving the delivery and efficacy of inhalation therapy products. Biral UK: +44 1275 847787 www.biral.com

Articles in this issue

Links on this page

view archives of Inhalation - INH0423